FDA lowers starting dose for sleep medication Lunesta
Thursday, May 15, 2014 - 17:00
in Health & Medicine
Alex CukanWASHINGTON, May 15 (UPI) -- The U.S. Food and Drug Administration said Thursday the manufacturer of Lunesta, or eszopiclone, must change the label to recommend a lower starting dose.